Global Peripherally Acting Anti-Obesity Drug Market Growth 2024-2030
A Peripherally Acting Anti-Obesity Drug is a medication designed to treat obesity by acting on the peripheral nervous system or other systems in the body. These drugs target various mechanisms involved in appetite regulation, metabolism, and fat absorption to aid in weight loss.
The global Peripherally Acting Anti-Obesity Drug market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Peripherally Acting Anti-Obesity Drug Industry Forecast” looks at past sales and reviews total world Peripherally Acting Anti-Obesity Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected Peripherally Acting Anti-Obesity Drug sales for 2024 through 2030. With Peripherally Acting Anti-Obesity Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripherally Acting Anti-Obesity Drug industry.
This Insight Report provides a comprehensive analysis of the global Peripherally Acting Anti-Obesity Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peripherally Acting Anti-Obesity Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peripherally Acting Anti-Obesity Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripherally Acting Anti-Obesity Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripherally Acting Anti-Obesity Drug.
United States market for Peripherally Acting Anti-Obesity Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Peripherally Acting Anti-Obesity Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Peripherally Acting Anti-Obesity Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Peripherally Acting Anti-Obesity Drug players cover Novo Nordisk A/S, Pfizer Inc., Boehringer Ingelheim International GmbH, KVK Tech Inc. and Gelesis Holdings, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripherally Acting Anti-Obesity Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Prescription Drugs
Non-prescription Drugs
Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novo Nordisk A/S
Pfizer Inc.
Boehringer Ingelheim International GmbH
KVK Tech Inc.
Gelesis Holdings
Vivus LLC.
Currax Pharmaceuticals LLC
GlaxoSmithKline plc
CHEPLAPHARM Arzneimittel GmbH
Rhythm Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Peripherally Acting Anti-Obesity Drug market?
What factors are driving Peripherally Acting Anti-Obesity Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Peripherally Acting Anti-Obesity Drug market opportunities vary by end market size?
How does Peripherally Acting Anti-Obesity Drug break out type, application?
Please note: The report will take approximately 2 business days to prepare and deliver.